22:15 , Sep 21, 2018 |  BC Extra  |  Clinical News

GTx shares crater after incontinence readout

GTx Inc. (NASDAQ:GTXI) shed 92% of its value Friday, falling from the small cap band to trading at roughly the value of its cash, after the company's enobosarm (GTx-024) failed in the Phase II ASTRID...
02:28 , May 18, 2018 |  BC Week In Review  |  Financial News

MEI Pharma raises $75M in private placement

MEI Pharma Inc. (NASDAQ:MEIP) raised $75 million on May 14 through the sale of 33 million units at $2.27 in a private placement led by Vivo Capital and CAM Capital. Also participating were New Enterprise...
17:52 , May 14, 2018 |  BC Extra  |  Financial News

MEI Pharma raises $75M in private placement

MEI Pharma Inc. (NASDAQ:MEIP) added $0.30 (13%) to $2.53 on Monday after it raised $75 million through the sale of 33 million units at $2.27 in a private placement led by Vivo Capital and CAM...
17:06 , Apr 6, 2018 |  BC Week In Review  |  Financial News

RA Capital leads Eidos' $64M series B round

Eidos Therapeutics Inc. (San Francisco, Calif.) raised a $64 million series B round led by new investor RA Capital. Eidos' parent company, BridgeBio Pharma LLC (Palo Alto, Calif.), also participated, as did new investors Janus...
15:49 , Apr 5, 2018 |  BC Extra  |  Financial News

RA Capital leads Eidos' $64M series B round

Eidos Therapeutics Inc. (San Francisco, Calif.) raised a $64 million series B round led by new investor RA Capital. Eidos' parent company, BridgeBio Pharma LLC (Palo Alto, Calif.), also participated, as did new investors Janus...
21:36 , Sep 29, 2017 |  BC Week In Review  |  Financial News

Public financing roundup: Kadmon, TherapeuticsMD, GTx, Newron

On Sept. 26, several biotechs announced public financing, including follow-ons from Kadmon Holdings Inc. (NYSE:KDMN) and TherapeuticsMD Inc. (NYSE-M:TXMD). Kadmon raised $80 million through the sale of 26.8 million shares at $3 in a bumped-up...
00:00 , Sep 27, 2017 |  BC Extra  |  Financial News

Public financing roundup: Kadmon, TherapeuticsMD, GTx, Newron

On Tuesday, several biotechs announced public financing, including follow-ons from Kadmon Holdings Inc. (NYSE:KDMN) and TherapeuticsMD Inc. (NYSE-M:TXMD). Kadmon raised $72 million through the sale of 24 million shares at $3 in a follow-on and...